STOCK TITAN

US Physical Therapy (USPH) Form 144 Filed for 2,000-Share Sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

US Physical Therapy, Inc. (USPH) submitted a Form 144 notifying a proposed sale of 2,000 shares of common stock through UBS Financial Services on the NYSE with an aggregate market value of $165,127.20. The shares were originally acquired as restricted stock grants on 04/01/2020 (3,089 shares acquired) and were paid as compensation on the acquisition date. The filing states there were no securities sold by the reporting person in the past three months. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

  • Full disclosure of proposed sale details including broker, share count, and aggregate market value
  • No reported sales by the reporting person in the past three months, as stated in the filing
  • Origin of shares disclosed (restricted stock grants acquired 04/01/2020) and payment method (compensation)

Negative

  • Insider intends to sell 2,000 shares which will be executed on the NYSE (aggregate value $165,127.20)
  • Outstanding share base disclosed (15,200,000) which contextualizes the sale as part of the public float

Insights

TL;DR: Insider plans a modest sale of 2,000 shares filed under Rule 144; filing is routine and adheres to disclosure requirements.

This Form 144 documents a proposed sale by a person who received restricted stock grants on 04/01/2020 and intends to sell 2,000 common shares via UBS on the NYSE with an indicated aggregate market value of $165,127.20. The filing notes no sales in the prior three months and includes the standard representation regarding material adverse information. For investors, this is a compliance disclosure of an intended transaction rather than a corporate operational update.

TL;DR: The notice is procedurally complete and signals an insider liquidity event based on prior compensation awards.

The report identifies the securities as compensation-based restricted stock grants originally recorded on 04/01/2020 and confirms payment was in connection with compensation. The use of a broker and the absence of other recent sales are disclosed. The filing meets Rule 144 notification norms and provides the required seller attestation about undisclosed material information.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does USPH's Form 144 disclose about the proposed sale?

The Form 144 discloses a proposed sale of 2,000 common shares via UBS Financial Services on the NYSE with aggregate market value of $165,127.20 and an approximate sale date of 09/04/2025.

When and how were the shares being sold by the USPH reporting person acquired?

The shares were acquired as restricted stock grants on 04/01/2020; the filing shows 3,089 shares were acquired and payment was recorded as compensation.

Has the reporting person sold any USPH securities in the past three months?

According to the Form 144, there is nothing to report for securities sold by the reporting person during the past three months.

Which broker and exchange are named for the proposed USPH sale?

The broker is UBS Financial Services Inc, 1000 Harbor Blvd, Weehawken NJ and the exchange named is the NYSE.

What representation does the seller make in the Form 144?

By signing the notice, the seller represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.
U S Physical Therapy

NYSE:USPH

USPH Rankings

USPH Latest News

USPH Latest SEC Filings

USPH Stock Data

1.30B
14.90M
1.94%
105.69%
4.3%
Medical Care Facilities
Services-health Services
Link
United States
HOUSTON